HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Camara, M. L. Articles by Caralps, J. M. Search for Related Content PubMed PubMed Citation Articles by Camara, M. L. Articles by Caralps, J. M.

The Annals of Thoracic Surgery, Vol 45, 133-136, Copyright © 1988 by The Society of Thoracic Surgeons

ARTICLES

Long-term results of mitral valve surgery in patients with severe pulmonary hypertension

ML Camara, A Aris, JM Padro and JM Caralps
Cardiac Surgery Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Mitral valve surgery was performed in 88 patients with severe pulmonary hypertension (average systolic pulmonary artery pressure, 94.7 +/- 22 mm Hg; range, 70-180 mm Hg) over a 10-year period. Sixty-four patients (73%) were in New York Heart Association Functional Class III or IV. There were 64 valve replacements and 24 open mitral commissurotomies. Operative mortality was 5.6% (5 patients) and was not related to the degree of pulmonary hypertension, surgical procedure performed, or type of valve lesion. A 100% follow-up was obtained, ranging from nine months to 10 years, with a mean of 44 months. Six late cardiac deaths (7.2%) occurred, 5 in patients with valve replacement and 1 in a patient who underwent a commissurotomy. Actuarial survival was 86 +/- 3% at five years and 83 +/- 4% at 10 years. Fourteen patients underwent right ventricular catheterization a mean of 24 months following operation. Systolic pulmonary artery pressure had decreased from a mean preoperative value of 101 +/- 22 to 40.5 +/- 7 mm Hg (p less than 0.001). Cardiac index increased by 55% of the preoperative values. Functional status improved markedly; 71 survivors (93%) were in New York Heart Association Class I or II. These results indicate that, in patients with mitral valve lesions and severe pulmonary hypertension, (1) surgical procedures can be performed with an acceptable operative mortality; (2) excellent long-term survival and functional results can be obtained; and (3) pulmonary hypertension decreases significantly after operation.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Shiran and A. Sagie Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J. Am. Coll. Cardiol., February 3, 2009; 53(5): 401 - 408. [Abstract] [Full Text] [PDF]

				M. Mubeen, A. K Singh, S. K Agarwal, J. Pillai, S. Kapoor, and A. K Srivastava Mitral Valve Replacement in Severe Pulmonary Arterial Hypertension Asian Cardiovasc Thorac Ann, February 1, 2008; 16(1): 37 - 42. [Abstract] [Full Text] [PDF]

				Long-term Results of Mitral Valve Surgery in Patients with Severe Pulmonary Hypertension Ann. Thorac. Surg., May 1, 1996; 61(5): 1583 - 1584. [Full Text]

				D. A. Fullerton, R. C. McIntyre Jr, L. E. Kirson, J. A. St. Cyr, G. J. R. Whitman, and F. L. Grover Impact of Respiratory Acid-Base Status in Patients With Pulmonary Hypertension Ann. Thorac. Surg., February 1, 1996; 61(2): 696 - 701. [Abstract] [Full Text]

				J. J. Vincens, D. Temizer, J. R. Post, L. H. Edmunds Jr, and H. C. Herrmann Long-term Outcome of Cardiac Surgery in Patients With Mitral Stenosis and Severe Pulmonary Hypertension Circulation, November 1, 1995; 92(9): 137 - 142. [Abstract] [Full Text]

				T. Berki, B. Kisacikoglu, A. Mete, A. Irez, O. Bayezid, and C. Yakut Surgical Treatment of Multivalvular Rheumatic Heart Disease Vascular and Endovascular Surgery, June 1, 1991; 25(5): 337 - 344. [Abstract] [PDF]